ORC ID ">
  • Users Online: 1911
  • Home
  • Print this page
  • Email this page
RESEARCH ARTICLE
Year : 2018  |  Volume : 13  |  Issue : 7  |  Page : 1247-1252

Controlled release of FK506 from micropatterned PLGA films: potential for application in peripheral nerve repair


1 Department of Bioengineering, University of Utah; Department of Surgery, University of Utah, Salt Lake City, UT, USA
2 Department of Bioengineering, University of Utah, Salt Lake City, UT, USA
3 Department of Surgery, University of Utah; Department of Mechanical Engineering, University of Utah, Salt Lake City, UT, USA
4 Department of Surgery, University of Utah, Salt Lake City, UT, USA
5 Department of Mechanical Engineering, University of Utah, Salt Lake City, UT, USA

Correspondence Address:
Jayant Agarwal
Department of Surgery, University of Utah, Salt Lake City, UT
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1673-5374.235063

Rights and Permissions

After decades of research, peripheral nerve injury and repair still frequently results in paralysis, chronic pain and neuropathies leading to severe disability in patients. Current clinically available nerve conduits only provide crude guidance of regenerating axons across nerve gap without additional functionality. FK506 (Tacrolimus), an FDA approved immunosuppressant, has been shown to enhance peripheral nerve regeneration but carries harsh side-effects when delivered systemically. The objective of this study was to develop and evaluate a bioresorbable drug delivery system capable of local extended delivery of FK506 that also provides topological guidance cues to guide axon growth via microgrooves. Photolithography was used to create micropatterned poly(lactide-co-glycolic acid) (PLGA) films embedded with FK506. Non-patterned, 10/10 μm (ridge/groove width), and 30/30 μm patterned films loaded with 0, 1, and 3 μg/cm2 FK506 were manufactured and characterized. In vitro FK506 rate of release testing indicated that the films are capable of an extended (at least 56 days), controlled, and scalable release of FK506. Neurite extension bioactivity assay indicated that FK506 released from the films (concentration of samples tested ranged between 8.46–19.7 ng/mL) maintained its neural bioactivity and promoted neurite extension similar to control FK506 dosages (10 ng/mL FK506). The multi-functional FK506 embedded, micropatterned poly(lactide-co-glycolic acid) films developed in this study have potential to be used in the construction of peripheral nerve repair devices.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2038    
    Printed29    
    Emailed0    
    PDF Downloaded264    
    Comments [Add]    
    Cited by others 8    

Recommend this journal